Cleavage by MALT1 induces cytosolic release of A20

被引:25
|
作者
Malinverni, Claire [1 ]
Unterreiner, Adeline [1 ]
Staal, Jens [2 ,3 ]
Demeyer, Annelies [2 ,3 ]
Galaup, Marion [1 ]
Luyten, Marcel [1 ]
Beyaert, Rudi [2 ,3 ]
Bornancin, Frederic [1 ]
机构
[1] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland
[2] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium
[3] VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, Ghent, Belgium
关键词
A20; Proteolysis; MALT1; DUB activity; NF-kappa B; T-CELL-ACTIVATION; KAPPA-B; INHIBITION; LYMPHOMA;
D O I
10.1016/j.bbrc.2010.08.091
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The MALT1 paracaspase has arginine-directed proteolytic activity. A20 is a dual ubiquitin-editing enzyme involved in termination of NF-kappa B signaling. Upon T- or B-cell receptor engagement human (h) A20 is cleaved by MALT1 after arginine 439, yielding an N-terminal fragment (hA20p50) and a C-terminal one (hA20p37). The hA20p50 fragment has never been detected directly, thus limiting insight into the functional consequences of MALT1-mediated cleavage of A20. Here, various antibodies were tested, including newly generated hA20p50 and hA20p37 specific antibodies, leading to detection of the hA20p50 fragment produced after MALT1-mediated cleavage of ectopically expressed as well as endogenous A20 proteins. The properties of both A20 fragments, generated upon co-expression with a constitutively active MALT1 protein, were further studied by sub-cellular fractionation and fluorescence microscopy. In contrast to full-length A20 which is particulate and insoluble, we found hA20p50 to be soluble and readily released into the cytosol whereas hA20p37 was partially soluble, thus suggesting loss of compartmentalization as a possible mechanism for MALT1-mediated dampening of A20 function. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:543 / 547
页数:5
相关论文
共 50 条
  • [31] Ways and waves of MALT1 paracaspase activation
    Laura Israël
    Frédéric Bornancin
    Cellular & Molecular Immunology, 2018, 15 : 8 - 11
  • [32] MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma
    Akyuz, Nuray
    Albert-Konetzny, Nadine
    Pott, Christiane
    Callet-Bauchu, Evelyne
    Bokemeyer, Carsten
    Penas, Eva Maria Murga
    Dierlamm, Judith
    LEUKEMIA & LYMPHOMA, 2017, 58 (10) : 2480 - 2484
  • [33] Mechanism and specificity of the human paracaspase MALT1
    Hachmann, Janna
    Snipas, Scott J.
    van Raam, Bram J.
    Cancino, Erik M.
    Houlihan, Emily J.
    Poreba, Marcin
    Kasperkiewicz, Paulina
    Drag, Marcin
    Salvesen, Guy S.
    BIOCHEMICAL JOURNAL, 2012, 443 : 287 - 295
  • [34] Development of new Malt1 inhibitors and probes
    Xin, Bo-Tao
    Schimmack, Gisela
    Du, Yimeng
    Florea, Bogdan I.
    van der Marel, Gijsbert A.
    Driessen, Christoph
    Krappmann, Daniel
    Overkleeft, Herman S.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (15) : 3312 - 3329
  • [35] Human MALT1 deficiency and predisposition to infections
    Lu, Henry Y.
    Turvey, Stuart E.
    CURRENT OPINION IN IMMUNOLOGY, 2021, 72 : 11 - 22
  • [36] Probes to Monitor Activity of the Paracaspase MALT1
    Hachmann, Janna
    Edgington-Mitchell, Laura E.
    Poreba, Marcin
    Sanman, Laura E.
    Drag, Marcin
    Bogyo, Matthew
    Salvesen, Guy S.
    CHEMISTRY & BIOLOGY, 2015, 22 (01): : 139 - 147
  • [37] Z-VRPR-FMK对Burkitt淋巴瘤细胞内MALT1和A20蛋白表达的影响
    王佳蕊
    冯江龙
    杨文秀
    贵州医科大学学报, 2017, (10) : 1125 - 1129
  • [38] MALT1 Rearrangements in BAL Fluid Response
    Kido, Takashi
    Yatera, Kazuhiro
    Mukae, Hiroshi
    CHEST, 2012, 142 (01) : 262 - 263
  • [39] MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage
    Klei, Linda R.
    Hu, Dong
    Panek, Robert
    Alfano, Danielle N.
    Bridwell, Rachel E.
    Bailey, Kelly M.
    Oravecz-Wilson, Katherine I.
    Concel, Vincent J.
    Hess, Emily M.
    Van Beek, Matthew
    Delekta, Phillip C.
    Gu, Shufang
    Watkins, Simon C.
    Ting, Adrian T.
    Gough, Peter J.
    Foley, Kevin P.
    Bertin, John
    McAllister-Lucas, Linda M.
    Lucas, Peter C.
    CELL REPORTS, 2016, 17 (01): : 221 - 232
  • [40] Development of PROTACs for targeted degradation of MALT1
    Jones, D.
    Gibbs, W.
    Ambler, M.
    Crompton, C.
    Saxty, B.
    Newman, M.
    Ansell, K.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E122 - E122